Intellia Therapeutics, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 413 | 0.0% | 45,948 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 348 | 0.0% | 37,056 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 259 | 0.0% | 36,419 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 559 | 0.0% | 47,915 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,100 | 0.0% | 53,545 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,213 | 0.0% | 54,192 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 1,820 | 0.0% | 66,166 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,928 | 0.0% | 63,231 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 2,166 | 0.0% | 68,495 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 2,355 | 0.0% | 57,744 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,392 | 0.0% | 64,170 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 2,239 | 0.0% | 63,847 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 3,014 | 0.0% | 54,151 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 2,847 | 0.0% | 54,693 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 3,609 | 0.0% | 49,800 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 4,177 | 0.0% | 35,019 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 4,669 | 0.0% | 34,804 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 5,757 | 0.0% | 35,558 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 2,464 | 0.0% | 30,700 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,631 | 0.0% | 29,982 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 563 | 0.0% | 28,316 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 538 | 0.0% | 26,340 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 310 | 0.0% | 25,364 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 351 | 0.0% | 23,938 | 12/31/2019 |